High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-07

AUTHORS

Jean Marc Phelip, Laurent Mineur, Christelle De la Fouchardière, Etienne Chatelut, Jean Louis Quesada, Xavier Roblin, Denis Pezet, Christophe Mendoza, Emmanuel Buc, Michel Rivoire

ABSTRACT

BACKGROUND: The purpose of this study was to assess the efficacy and tolerance of induction chemotherapy combining LV5FU2 with increased doses of irinotecan adapted to UGT1A1 genotyping and cetuximab in untreated potentially resectable liver metastases of colorectal cancer. METHODS: Twenty-six patients, PS 0-1, with class II hepatic metastases received chemotherapy combining irinotecan 260 mg/m(2) on day 1 for UGT1A1 6/6 and 6/7 genotypes and 220 mg/m(2) for UGT1A1 7/7 genotypes, with leucovorin on day 1, 5FU 400 mg/m(2) bolus on day 1 and continuous 5FU infusion for 46 h, and cetuximab on day 1 (day 1 = day 14). Primary prevention with lenograstim (day 5-9) was given to UGT1A1 6/7 and 7/7 genotypes. The primary endpoint was the response rate (RECIST1.1), and the secondary endpoints were tolerance (NCI-CTC criteria) and R0 resection rate. RESULTS: The average number of cycles per patient was 6 (±1.9). The UGT1A1 genotype was 6/6 in 34.6 %, 6/7 in 53.9 %, and 7/7 in 11.5 % of patients. At 6 cycles, 18 patients (69.2 %) presented a partial response, 5 patients (19.2 %) had stable disease, 2 patients (7.7 %) died independently of chemotherapy, and 1 patient (3.9 %) refused the treatment after 3 cycles. Four patients received 2 more cycles and the cumulative response rate at 8 cycles was 76.9 % (20/26). There was no progression. Among assessable patients (n = 23), the overall response rate was 82.6 % and 21 patients (80.7 %) had a metastasis resection. The most frequent grade 3-4 toxicities were neutropenia (31 %), diarrhea (20.8 %), and anorexia (16.4 %). There were no deaths due to toxicity. CONCLUSIONS: High-dose FOLFIRI combined with cetuximab yielded high response rates and enabled complete resection of class II hepatic metastases in most patients. It seemed to be well-tolerated among healthy selected patients thanks to irinotecan dose adaptation according to UGT1A1 pharmacogenomics status. This intensified chemotherapy regimen needs to be confirmed in a randomized, phase III study. More... »

PAGES

2161-2166

Identifiers

URI

http://scigraph.springernature.com/pub.10.1245/s10434-015-5072-4

DOI

http://dx.doi.org/10.1245/s10434-015-5072-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1042130297

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26739304


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Camptothecin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cetuximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glucuronosyltransferase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leucovorin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Gastroenterology and Digestive Oncology, LINA EA4624 Jean Monet University, University Hospital of Saint Etienne, 42055, Saint Etienne Cedex 2, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Phelip", 
        "givenName": "Jean Marc", 
        "id": "sg:person.0775434225.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775434225.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sainte Catherine Institute, Avignon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mineur", 
        "givenName": "Laurent", 
        "id": "sg:person.01167577531.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167577531.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Leon Berard Center, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De la Fouchardi\u00e8re", 
        "givenName": "Christelle", 
        "id": "sg:person.01304763136.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304763136.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Claudius Regaud Institute, Toulouse, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chatelut", 
        "givenName": "Etienne", 
        "id": "sg:person.01333606250.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333606250.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Grenoble", 
          "id": "https://www.grid.ac/institutes/grid.410529.b", 
          "name": [
            "University Hospital of Grenoble, Grenoble, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quesada", 
        "givenName": "Jean Louis", 
        "id": "sg:person.01233725247.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233725247.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Gastroenterology and Digestive Oncology, LINA EA4624 Jean Monet University, University Hospital of Saint Etienne, 42055, Saint Etienne Cedex 2, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roblin", 
        "givenName": "Xavier", 
        "id": "sg:person.01171101435.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171101435.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "University Hospital of Clermont Ferrand, Clermont Ferrand, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pezet", 
        "givenName": "Denis", 
        "id": "sg:person.0620372753.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620372753.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Grenoble", 
          "id": "https://www.grid.ac/institutes/grid.410529.b", 
          "name": [
            "University Hospital of Grenoble, Grenoble, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mendoza", 
        "givenName": "Christophe", 
        "id": "sg:person.01302525540.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302525540.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "University Hospital of Clermont Ferrand, Clermont Ferrand, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Buc", 
        "givenName": "Emmanuel", 
        "id": "sg:person.0760510232.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760510232.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Leon Berard Center, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rivoire", 
        "givenName": "Michel", 
        "id": "sg:person.01174146046.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174146046.11"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1634/theoncologist.2011-0141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013432328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa032691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014051315"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000145964.08365.01", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022055193"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000145964.08365.01", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022055193"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2014.02.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023713618"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-013-3217-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026675663", 
          "https://doi.org/10.1245/s10434-013-3217-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdi246", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028947330"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.0928", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029306962"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1305275", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030588737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bjs.7032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030884899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bjs.7032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030884899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mds236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034294500"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-010-1166-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034900487", 
          "https://doi.org/10.1245/s10434-010-1166-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-010-1166-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034900487", 
          "https://doi.org/10.1245/s10434-010-1166-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000138352", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036000132"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.44.8308", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037604585"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0805019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045468727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.20.8397", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046361202"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.19.0314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046438012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.07.113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046620703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.07.113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046620703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.19.9273", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047377641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/tpj.2013.10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049682445", 
          "https://doi.org/10.1038/tpj.2013.10"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000138076.72547.b1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049859213"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000138076.72547.b1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049859213"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(09)70330-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050539676"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-07", 
    "datePublishedReg": "2016-07-01", 
    "description": "BACKGROUND: The purpose of this study was to assess the efficacy and tolerance of induction chemotherapy combining LV5FU2 with increased doses of irinotecan adapted to UGT1A1 genotyping and cetuximab in untreated potentially resectable liver metastases of colorectal cancer.\nMETHODS: Twenty-six patients, PS 0-1, with class II hepatic metastases received chemotherapy combining irinotecan 260\u00a0mg/m(2) on day 1 for UGT1A1 6/6 and 6/7 genotypes and 220\u00a0mg/m(2) for UGT1A1 7/7 genotypes, with leucovorin on day 1, 5FU 400\u00a0mg/m(2) bolus on day 1 and continuous 5FU infusion for 46\u00a0h, and cetuximab on day 1 (day 1\u00a0=\u00a0day 14). Primary prevention with lenograstim (day 5-9) was given to UGT1A1 6/7 and 7/7 genotypes. The primary endpoint was the response rate (RECIST1.1), and the secondary endpoints were tolerance (NCI-CTC criteria) and R0 resection rate.\nRESULTS: The average number of cycles per patient was 6 (\u00b11.9). The UGT1A1 genotype was 6/6 in 34.6\u00a0%, 6/7 in 53.9\u00a0%, and 7/7 in 11.5\u00a0% of patients. At 6 cycles, 18 patients (69.2\u00a0%) presented a partial response, 5 patients (19.2\u00a0%) had stable disease, 2 patients (7.7\u00a0%) died independently of chemotherapy, and 1 patient (3.9\u00a0%) refused the treatment after 3 cycles. Four patients received 2 more cycles and the cumulative response rate at 8 cycles was 76.9\u00a0% (20/26). There was no progression. Among assessable patients (n\u00a0=\u00a023), the overall response rate was 82.6\u00a0% and 21 patients (80.7\u00a0%) had a metastasis resection. The most frequent grade 3-4 toxicities were neutropenia (31\u00a0%), diarrhea (20.8\u00a0%), and anorexia (16.4\u00a0%). There were no deaths due to toxicity.\nCONCLUSIONS: High-dose FOLFIRI combined with cetuximab yielded high response rates and enabled complete resection of class II hepatic metastases in most patients. It seemed to be well-tolerated among healthy selected patients thanks to irinotecan dose adaptation according to UGT1A1 pharmacogenomics status. This intensified chemotherapy regimen needs to be confirmed in a randomized, phase III study.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1245/s10434-015-5072-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "23"
      }
    ], 
    "name": "High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT)", 
    "pagination": "2161-2166", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c8affb47784645ec80484fc13ca28d9c6cb5101042423981c229be4b982b1186"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26739304"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9420840"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1245/s10434-015-5072-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1042130297"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1245/s10434-015-5072-4", 
      "https://app.dimensions.ai/details/publication/pub.1042130297"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000500.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1245/s10434-015-5072-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1245/s10434-015-5072-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1245/s10434-015-5072-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1245/s10434-015-5072-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1245/s10434-015-5072-4'


 

This table displays all metadata directly associated to this object as RDF triples.

286 TRIPLES      21 PREDICATES      68 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1245/s10434-015-5072-4 schema:about N12b6a0cd37014b87a328d01131e594ee
2 N1398c88071584a409ba44fd390773304
3 N16c4f8135c04435cb670716da19f6cb2
4 N1783931dac6f4655a2149a3c2279a144
5 N17e18d566382496e994582b46bffe200
6 N2288fbd6aca1447497f2595652ce515e
7 N2729d4602c8649b7a573455fafd54829
8 N4186ae753175416d8e63b1cdde524f39
9 N66cfc5212f7b4b6992c56d9ba46ddea9
10 N7d8515dea38b4c419c50dd4b4a8a9dd7
11 N814ed24470ee4e798e213303867e6612
12 N82c1cac22c7c4f5082ad8cb4e8331b72
13 N8c171422a60442ecb63486399bb458f0
14 Na506d97dedfd419fab53bedd8bcc484f
15 Nac50807bbdf540739842c43f6b575bf8
16 Ncd071c09eb4a42b9b33a43e38df5b571
17 Ne021f1a43f9a4146b869a9f046711cce
18 Nf41fa8266aa74625a7a266e3eff48124
19 anzsrc-for:11
20 anzsrc-for:1112
21 schema:author N242d936e99884ec4a46d6b582b2f0f7d
22 schema:citation sg:pub.10.1038/tpj.2013.10
23 sg:pub.10.1245/s10434-010-1166-1
24 sg:pub.10.1245/s10434-013-3217-x
25 https://doi.org/10.1002/bjs.7032
26 https://doi.org/10.1016/j.ejca.2014.02.024
27 https://doi.org/10.1016/s1470-2045(09)70330-4
28 https://doi.org/10.1056/nejmoa032691
29 https://doi.org/10.1056/nejmoa0805019
30 https://doi.org/10.1056/nejmoa1305275
31 https://doi.org/10.1093/annonc/mdi246
32 https://doi.org/10.1093/annonc/mds236
33 https://doi.org/10.1097/01.sla.0000138076.72547.b1
34 https://doi.org/10.1097/01.sla.0000145964.08365.01
35 https://doi.org/10.1159/000138352
36 https://doi.org/10.1200/jco.2005.07.113
37 https://doi.org/10.1200/jco.2006.09.0928
38 https://doi.org/10.1200/jco.2008.19.0314
39 https://doi.org/10.1200/jco.2008.19.9273
40 https://doi.org/10.1200/jco.2008.20.8397
41 https://doi.org/10.1200/jco.2012.44.8308
42 https://doi.org/10.1634/theoncologist.2011-0141
43 schema:datePublished 2016-07
44 schema:datePublishedReg 2016-07-01
45 schema:description BACKGROUND: The purpose of this study was to assess the efficacy and tolerance of induction chemotherapy combining LV5FU2 with increased doses of irinotecan adapted to UGT1A1 genotyping and cetuximab in untreated potentially resectable liver metastases of colorectal cancer. METHODS: Twenty-six patients, PS 0-1, with class II hepatic metastases received chemotherapy combining irinotecan 260 mg/m(2) on day 1 for UGT1A1 6/6 and 6/7 genotypes and 220 mg/m(2) for UGT1A1 7/7 genotypes, with leucovorin on day 1, 5FU 400 mg/m(2) bolus on day 1 and continuous 5FU infusion for 46 h, and cetuximab on day 1 (day 1 = day 14). Primary prevention with lenograstim (day 5-9) was given to UGT1A1 6/7 and 7/7 genotypes. The primary endpoint was the response rate (RECIST1.1), and the secondary endpoints were tolerance (NCI-CTC criteria) and R0 resection rate. RESULTS: The average number of cycles per patient was 6 (±1.9). The UGT1A1 genotype was 6/6 in 34.6 %, 6/7 in 53.9 %, and 7/7 in 11.5 % of patients. At 6 cycles, 18 patients (69.2 %) presented a partial response, 5 patients (19.2 %) had stable disease, 2 patients (7.7 %) died independently of chemotherapy, and 1 patient (3.9 %) refused the treatment after 3 cycles. Four patients received 2 more cycles and the cumulative response rate at 8 cycles was 76.9 % (20/26). There was no progression. Among assessable patients (n = 23), the overall response rate was 82.6 % and 21 patients (80.7 %) had a metastasis resection. The most frequent grade 3-4 toxicities were neutropenia (31 %), diarrhea (20.8 %), and anorexia (16.4 %). There were no deaths due to toxicity. CONCLUSIONS: High-dose FOLFIRI combined with cetuximab yielded high response rates and enabled complete resection of class II hepatic metastases in most patients. It seemed to be well-tolerated among healthy selected patients thanks to irinotecan dose adaptation according to UGT1A1 pharmacogenomics status. This intensified chemotherapy regimen needs to be confirmed in a randomized, phase III study.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree false
49 schema:isPartOf N1395b48b5a1541f7a2aec59df9d9ab28
50 Nea9cdb914c124f5cbf69553fd1908abe
51 sg:journal.1105545
52 schema:name High Resectability Rate of Initially Unresectable Colorectal Liver Metastases After UGT1A1-Adapted High-Dose Irinotecan Combined with LV5FU2 and Cetuximab: A Multicenter Phase II Study (ERBIFORT)
53 schema:pagination 2161-2166
54 schema:productId N4665c7a37faf42f6850624366ef296ff
55 N67977941978645988684f9bce7e0c2d7
56 N716729e5dac8473698a3581f4d8acf5f
57 N7d3053c7095f40239bcc5927f858de6d
58 Ndc9d7261451f44f6afcff2baa1c4cc08
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042130297
60 https://doi.org/10.1245/s10434-015-5072-4
61 schema:sdDatePublished 2019-04-10T15:48
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N2803ba384b1b4cc4b6c292fe2635a6a0
64 schema:url http://link.springer.com/10.1245/s10434-015-5072-4
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N045c0902440443da96886dafde2af50b schema:name Leon Berard Center, Lyon, France
69 rdf:type schema:Organization
70 N08ef3e42cc044e44b823b31ecfac116d rdf:first sg:person.01302525540.20
71 rdf:rest N3aaeb9c934ea40edb7dc82b4f99d778d
72 N12b6a0cd37014b87a328d01131e594ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Aged
74 rdf:type schema:DefinedTerm
75 N1395b48b5a1541f7a2aec59df9d9ab28 schema:volumeNumber 23
76 rdf:type schema:PublicationVolume
77 N1398c88071584a409ba44fd390773304 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Leucovorin
79 rdf:type schema:DefinedTerm
80 N1586443dfe914e06ad32b3969ae13ce3 rdf:first sg:person.01171101435.68
81 rdf:rest Ne39dd4de1ae84eb797fdca74a4c93c9d
82 N16c4f8135c04435cb670716da19f6cb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Colorectal Neoplasms
84 rdf:type schema:DefinedTerm
85 N1783931dac6f4655a2149a3c2279a144 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Humans
87 rdf:type schema:DefinedTerm
88 N17e18d566382496e994582b46bffe200 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Camptothecin
90 rdf:type schema:DefinedTerm
91 N2288fbd6aca1447497f2595652ce515e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Cetuximab
93 rdf:type schema:DefinedTerm
94 N242d936e99884ec4a46d6b582b2f0f7d rdf:first sg:person.0775434225.92
95 rdf:rest Nc35e37ed12aa4d92b07d6cb9cb053048
96 N2729d4602c8649b7a573455fafd54829 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Female
98 rdf:type schema:DefinedTerm
99 N2803ba384b1b4cc4b6c292fe2635a6a0 schema:name Springer Nature - SN SciGraph project
100 rdf:type schema:Organization
101 N3aaeb9c934ea40edb7dc82b4f99d778d rdf:first sg:person.0760510232.20
102 rdf:rest Nc17336df5d484679b85cb3429eb5013f
103 N4186ae753175416d8e63b1cdde524f39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Combined Modality Therapy
105 rdf:type schema:DefinedTerm
106 N437c18d43ec9458dbc362ed0ea703a9b schema:name University Hospital of Clermont Ferrand, Clermont Ferrand, France
107 rdf:type schema:Organization
108 N442940eb615545a7a297c7df3462576f schema:name Leon Berard Center, Lyon, France
109 rdf:type schema:Organization
110 N4665c7a37faf42f6850624366ef296ff schema:name readcube_id
111 schema:value c8affb47784645ec80484fc13ca28d9c6cb5101042423981c229be4b982b1186
112 rdf:type schema:PropertyValue
113 N5a90f40663e847f9b1853da385545c3d schema:name University Hospital of Clermont Ferrand, Clermont Ferrand, France
114 rdf:type schema:Organization
115 N66cfc5212f7b4b6992c56d9ba46ddea9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Antineoplastic Combined Chemotherapy Protocols
117 rdf:type schema:DefinedTerm
118 N67977941978645988684f9bce7e0c2d7 schema:name doi
119 schema:value 10.1245/s10434-015-5072-4
120 rdf:type schema:PropertyValue
121 N716729e5dac8473698a3581f4d8acf5f schema:name pubmed_id
122 schema:value 26739304
123 rdf:type schema:PropertyValue
124 N7d3053c7095f40239bcc5927f858de6d schema:name dimensions_id
125 schema:value pub.1042130297
126 rdf:type schema:PropertyValue
127 N7d8515dea38b4c419c50dd4b4a8a9dd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Prognosis
129 rdf:type schema:DefinedTerm
130 N814ed24470ee4e798e213303867e6612 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Male
132 rdf:type schema:DefinedTerm
133 N82c1cac22c7c4f5082ad8cb4e8331b72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Follow-Up Studies
135 rdf:type schema:DefinedTerm
136 N86fd588b3b384894bb4aaee17aa82e8f schema:name Claudius Regaud Institute, Toulouse, France
137 rdf:type schema:Organization
138 N8c171422a60442ecb63486399bb458f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Glucuronosyltransferase
140 rdf:type schema:DefinedTerm
141 N8cd18f0af6ce49359866da668584893a rdf:first sg:person.01233725247.78
142 rdf:rest N1586443dfe914e06ad32b3969ae13ce3
143 N8eb938d3350f43c999f485f708bd0bea schema:name Sainte Catherine Institute, Avignon, France
144 rdf:type schema:Organization
145 N8fa6bfd8c52e4f159d8aa8b06bd3bc5d rdf:first sg:person.01333606250.74
146 rdf:rest N8cd18f0af6ce49359866da668584893a
147 Na506d97dedfd419fab53bedd8bcc484f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Fluorouracil
149 rdf:type schema:DefinedTerm
150 Nac50807bbdf540739842c43f6b575bf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Survival Rate
152 rdf:type schema:DefinedTerm
153 Nc17336df5d484679b85cb3429eb5013f rdf:first sg:person.01174146046.11
154 rdf:rest rdf:nil
155 Nc35e37ed12aa4d92b07d6cb9cb053048 rdf:first sg:person.01167577531.59
156 rdf:rest Ne89fa020f8ba4f9b8d853c7e355897e4
157 Ncd071c09eb4a42b9b33a43e38df5b571 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Liver Neoplasms
159 rdf:type schema:DefinedTerm
160 Ndb47780aa2bc41b29d0857961f4aadaa schema:name Department of Gastroenterology and Digestive Oncology, LINA EA4624 Jean Monet University, University Hospital of Saint Etienne, 42055, Saint Etienne Cedex 2, France
161 rdf:type schema:Organization
162 Ndb50e4f11b6d4f16bbe27d2ed42d6bb3 schema:name Department of Gastroenterology and Digestive Oncology, LINA EA4624 Jean Monet University, University Hospital of Saint Etienne, 42055, Saint Etienne Cedex 2, France
163 rdf:type schema:Organization
164 Ndc9d7261451f44f6afcff2baa1c4cc08 schema:name nlm_unique_id
165 schema:value 9420840
166 rdf:type schema:PropertyValue
167 Ne021f1a43f9a4146b869a9f046711cce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Middle Aged
169 rdf:type schema:DefinedTerm
170 Ne39dd4de1ae84eb797fdca74a4c93c9d rdf:first sg:person.0620372753.15
171 rdf:rest N08ef3e42cc044e44b823b31ecfac116d
172 Ne89fa020f8ba4f9b8d853c7e355897e4 rdf:first sg:person.01304763136.25
173 rdf:rest N8fa6bfd8c52e4f159d8aa8b06bd3bc5d
174 Nea9cdb914c124f5cbf69553fd1908abe schema:issueNumber 7
175 rdf:type schema:PublicationIssue
176 Nf41fa8266aa74625a7a266e3eff48124 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Adult
178 rdf:type schema:DefinedTerm
179 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
180 schema:name Medical and Health Sciences
181 rdf:type schema:DefinedTerm
182 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
183 schema:name Oncology and Carcinogenesis
184 rdf:type schema:DefinedTerm
185 sg:journal.1105545 schema:issn 1068-9265
186 1534-4681
187 schema:name Annals of Surgical Oncology
188 rdf:type schema:Periodical
189 sg:person.01167577531.59 schema:affiliation N8eb938d3350f43c999f485f708bd0bea
190 schema:familyName Mineur
191 schema:givenName Laurent
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167577531.59
193 rdf:type schema:Person
194 sg:person.01171101435.68 schema:affiliation Ndb47780aa2bc41b29d0857961f4aadaa
195 schema:familyName Roblin
196 schema:givenName Xavier
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171101435.68
198 rdf:type schema:Person
199 sg:person.01174146046.11 schema:affiliation N045c0902440443da96886dafde2af50b
200 schema:familyName Rivoire
201 schema:givenName Michel
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174146046.11
203 rdf:type schema:Person
204 sg:person.01233725247.78 schema:affiliation https://www.grid.ac/institutes/grid.410529.b
205 schema:familyName Quesada
206 schema:givenName Jean Louis
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233725247.78
208 rdf:type schema:Person
209 sg:person.01302525540.20 schema:affiliation https://www.grid.ac/institutes/grid.410529.b
210 schema:familyName Mendoza
211 schema:givenName Christophe
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302525540.20
213 rdf:type schema:Person
214 sg:person.01304763136.25 schema:affiliation N442940eb615545a7a297c7df3462576f
215 schema:familyName De la Fouchardière
216 schema:givenName Christelle
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304763136.25
218 rdf:type schema:Person
219 sg:person.01333606250.74 schema:affiliation N86fd588b3b384894bb4aaee17aa82e8f
220 schema:familyName Chatelut
221 schema:givenName Etienne
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333606250.74
223 rdf:type schema:Person
224 sg:person.0620372753.15 schema:affiliation N437c18d43ec9458dbc362ed0ea703a9b
225 schema:familyName Pezet
226 schema:givenName Denis
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620372753.15
228 rdf:type schema:Person
229 sg:person.0760510232.20 schema:affiliation N5a90f40663e847f9b1853da385545c3d
230 schema:familyName Buc
231 schema:givenName Emmanuel
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760510232.20
233 rdf:type schema:Person
234 sg:person.0775434225.92 schema:affiliation Ndb50e4f11b6d4f16bbe27d2ed42d6bb3
235 schema:familyName Phelip
236 schema:givenName Jean Marc
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775434225.92
238 rdf:type schema:Person
239 sg:pub.10.1038/tpj.2013.10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049682445
240 https://doi.org/10.1038/tpj.2013.10
241 rdf:type schema:CreativeWork
242 sg:pub.10.1245/s10434-010-1166-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034900487
243 https://doi.org/10.1245/s10434-010-1166-1
244 rdf:type schema:CreativeWork
245 sg:pub.10.1245/s10434-013-3217-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1026675663
246 https://doi.org/10.1245/s10434-013-3217-x
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1002/bjs.7032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030884899
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1016/j.ejca.2014.02.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023713618
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/s1470-2045(09)70330-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050539676
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1056/nejmoa032691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014051315
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1056/nejmoa0805019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045468727
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1056/nejmoa1305275 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030588737
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1093/annonc/mdi246 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028947330
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1093/annonc/mds236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034294500
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1097/01.sla.0000138076.72547.b1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049859213
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1097/01.sla.0000145964.08365.01 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022055193
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1159/000138352 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036000132
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1200/jco.2005.07.113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046620703
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1200/jco.2006.09.0928 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029306962
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1200/jco.2008.19.0314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046438012
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1200/jco.2008.19.9273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047377641
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2008.20.8397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046361202
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1200/jco.2012.44.8308 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037604585
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1634/theoncologist.2011-0141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013432328
283 rdf:type schema:CreativeWork
284 https://www.grid.ac/institutes/grid.410529.b schema:alternateName Centre Hospitalier Universitaire de Grenoble
285 schema:name University Hospital of Grenoble, Grenoble, France
286 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...